Literature DB >> 34919967

Importance of Utilizing Natural Isotopologue Transitions in Expanding the Linear Dynamic Range of LC-MS/MS Assay for Small-Molecule Pharmacokinetic Sample Analysis - A Mini-review.

Thanh Bach1, Guohua An2.   

Abstract

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a widely used quantitative method in small-molecule pharmacokinetic sample analysis. The linear dynamic range of mass analyzers, typically spanning 3 orders of magnitude, is usually insufficient for this purpose. Utilization of multiple isotopologues has been proposed as a compelling approach to expand the linear dynamic range of LC-MS/MS assays, particularly when the detector is saturated. Isotopologues are a statistical mixture of molecules of the same compound but of different exact masses due to the presence of natural chemical isotopes. While the concept of isotopologues is widely recognized in large-molecule bioanalysis and small-molecule metabolite profiling, it has not been commonly implemented in small-molecule targeted quantification. To increase the awareness of the value of isotopologues in small-molecule LC-MS/MS analysis, this minireview provides the basis of isotopologue distribution in MS/MS and summarizes published studies as well as our own experience in utilizing multiple isotopologues to expand the linear dynamic range of small-molecule LC-MS/MS assays. Considering that utilizing natural isotopologue transitions in the LC-MS/MS assays represents an easy, straightforward, and robust way to expand the linear dynamic range, we believe this method deserves wide application in small-molecule pharmacokinetic sample analysis and can particularly benefit people working in pharmacokinetic labs as well as the GLP bioanalytical labs in pharmaceutical industry.
Copyright © 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Isotopologues; LCMS; Linear dynamic range; Natural isotopologue transitions; Small-molecule pharmacokinetics

Mesh:

Substances:

Year:  2021        PMID: 34919967      PMCID: PMC9018470          DOI: 10.1016/j.xphs.2021.12.012

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.784


  16 in total

1.  Stable isotopic characterization of active pharmaceutical ingredients.

Authors:  J P Jasper; B J Westenberger; J A Spencer; L F Buhse; M Nasr
Journal:  J Pharm Biomed Anal       Date:  2004-04-01       Impact factor: 3.935

2.  Expanding the linear dynamic range for multiple reaction monitoring in quantitative liquid chromatography-tandem mass spectrometry utilizing natural isotopologue transitions.

Authors:  Hanghui Liu; Lily Lam; Purnendu K Dasgupta
Journal:  Talanta       Date:  2011-10-05       Impact factor: 6.057

3.  Stable isotopic composition of the active pharmaceutical ingredient (API) naproxen.

Authors:  A M Wokovich; J A Spencer; B J Westenberger; L F Buhse; J P Jasper
Journal:  J Pharm Biomed Anal       Date:  2005-04-14       Impact factor: 3.935

4.  Expanding the linear dynamic range for quantitative liquid chromatography-high resolution mass spectrometry utilizing natural isotopologue signals.

Authors:  Hanghui Liu; Lily Lam; Lin Yan; Bert Chi; Purnendu K Dasgupta
Journal:  Anal Chim Acta       Date:  2014-08-04       Impact factor: 6.558

5.  Increasing the linear dynamic range in LC-MS: is it valid to use a less abundant isotopologue?

Authors:  Stephen Trobbiani; Peter Stockham; Timothy Scott
Journal:  Drug Test Anal       Date:  2017-04-17       Impact factor: 3.345

6.  Simultaneous determination of seven β-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies.

Authors:  Fekade Bruck Sime; Michael S Roberts; Jason A Roberts; Thomas A Robertson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-04-24       Impact factor: 3.205

7.  Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation.

Authors:  Ronilda D'Cunha; Thanh Bach; Beth Ann Young; Peizhi Li; Demet Nalbant; Jun Zhang; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

8.  Profiting from Probability; Combining Low and High Probability Isotopes as a Tool Extending the Dynamic Range of an Assay Measuring Amphetamine and Methamphetamine in Urine.

Authors:  Anna M Miller; Melissa M Goggin; An Nguyen; Stephanie D Gozum; Gregory C Janis
Journal:  J Anal Toxicol       Date:  2017-06-01       Impact factor: 3.367

9.  Development and validation of a simple, fast, and sensitive LC/MS/MS method for the quantification of oxfendazole in human plasma and its application to clinical pharmacokinetic study.

Authors:  Thanh Bach; SoHyun Bae; Ronilda D'Cunha; Patricia Winokur; Guohua An
Journal:  J Pharm Biomed Anal       Date:  2019-03-26       Impact factor: 3.935

10.  Aspects of matrix and analyte effects in clinical pharmacokinetic sample analyses using LC-ESI/MS/MS - Two case examples.

Authors:  Guohua An; Thanh Bach; Inas Abdallah; Demet Nalbant
Journal:  J Pharm Biomed Anal       Date:  2020-01-30       Impact factor: 3.935

View more
  1 in total

Review 1.  Application of Proteomics in the Discovery of Radiosensitive Cancer Biomarkers.

Authors:  Hui Luo; Hong Ge
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.